Onderneming Joinn Laboratories(China)Co.,Ltd. Hong Kong S.E.
Aandelen
6127
CNE100004BP3
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,45 HKD | +0,84% | -2,76% | -34,29% |
30/04 | JOINN LABORATORIES(CHINA)CO.,LTD. : Nomura handhaaft het Neutraal advies | ZM |
30/04 | JOINN LABORATORIES(CHINA)CO.,LTD. : Nomura herhaalt het Neutraal advies | ZM |
Vakgebied
Aantal werknemers: 2 510
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drug Non-clinical Research Services
97,3
%
| 2 215 | 97,7 % | 2 313 | 97,3 % | +4,41% |
Inter-segment Elimination
-6,2
%
| -436 | -19,2 % | -147 | -6,2 % | -66,33% |
Experimental Model Supply
6,2
%
| 439 | 19,3 % | 146 | 6,2 % | -66,63% |
Clinical Services and Others
2,7
%
| 50 | 2,2 % | 64 | 2,7 % | +28,41% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
75,6
%
| 1 885 | 83,1 % | 1 798 | 75,6 % | -4,64% |
Overseas
24,4
%
| 383 | 16,9 % | 579 | 24,4 % | +51,20% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 42 | 01-11-12 |
Ai Shui Yu
DFI | Director of Finance/CFO | 48 | 01-07-19 |
Ye Li
CHM | Chairman | 42 | 01-01-07 |
Ying Jun He
BRD | Director/Board Member | 49 | 01-08-21 |
Da Lin Yao
BRD | Director/Board Member | 75 | 01-02-12 |
Li Li Yin
BRD | Director/Board Member | 44 | 01-01-06 |
Yun Xia Sun
BRD | Director/Board Member | 56 | 01-10-99 |
Cong Lin Zuo
BRD | Director/Board Member | 60 | 01-12-96 |
Feng Song Jia
IRC | Investor Relations Contact | - | - |
Ka Lun Cheung
SEC | Corporate Secretary | - | 28-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yu Xia Feng
FOU | Founder | 60 | 11-08-95 |
Cong Lin Zuo
BRD | Director/Board Member | 60 | 01-12-96 |
Yun Xia Sun
BRD | Director/Board Member | 56 | 01-10-99 |
Da Peng Gao
CEO | Chief Executive Officer | 42 | 01-11-12 |
Ye Li
CHM | Chairman | 42 | 01-01-07 |
Li Li Yin
BRD | Director/Board Member | 44 | 01-01-06 |
Hui Ye Sun
BRD | Director/Board Member | 56 | 01-01-06 |
Da Lin Yao
BRD | Director/Board Member | 75 | 01-02-12 |
Yong Gong Zhai
BRD | Director/Board Member | 63 | 28-01-19 |
Xiao Jie Ou
BRD | Director/Board Member | 51 | 28-01-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 118 995 206 | 110 449 726 ( 92,82 %) | 0 | 59,26 % |
Aandeel B | 1 | 630 893 493 | 333 961 028 ( 52,93 %) | 6 257 246 ( 0,9918 %) |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
46 500 | 0.01% | 105 245 $ |
Bedrijfsgegevens
JOINN Laboratories (China) Co., Ltd.
5-A Rongjing East Street Beijing Economic-Tech & Dev Zone
100176, Beijing
+
http://www.joinn-lab.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |
- Beurs
- Aandelen
- Koers 603127
- Koers 6127
- Onderneming Joinn Laboratories(China)Co.,Ltd.